Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ispinesib in Recurrent or Metastatic Head and Neck Cancer
NCT00095628Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2005
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ispinesib in head and neck squamous cell carcinoma (HNSCC), sponsored by National Cancer Institute. Started Jan 2005; status: completed.
02
Drugs
ispinesib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00095628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00095628.